Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/17459
Title: The good, the (not so) bad and the ugly of immune homeostasis in melanoma.
Authors: da Gama Duarte, Jessica;Woods, Katherine;Andrews, Miles C;Behren, Andreas
Affiliation: Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia
MD Anderson Cancer Center, University of Texas, Houston, TX, USA
Issue Date: 2-Feb-2018
EDate: 2018
Citation: Immunology and cell biology 2018; online first: 2 February
Abstract: Within the immune system multiple mechanisms balance the need for efficient pathogen recognition and destruction with the prevention of tissue damage by excessive, inappropriate or even self-targeting (auto)immune reactions. This immune homeostasis is a tightly regulated system which fails during tumor development, often due to the hijacking of its essential self-regulatory mechanisms by cancer cells. It is facilitated not only by tumor intrinsic properties, but also by the microbiome, host genetics and other factors. In certain ways many cancers can therefore be considered a rare failure of immune control rather than an uncommon or rare disease of the tissue of origin, as the acquisition of potentially oncogenic traits through mutation occurs constantly in most tissues during proliferation. Normally, aberrant cells are well-controlled by cell intrinsic (repair or apoptosis) and extrinsic (immune) mechanisms. However, occasionally oncogenic cells survive and escape control. Melanoma is one of the first cancer types where treatments aimed at restoring and enhancing an immune response to regain control over the tumor have been used with various success rates. With the advent of "modern" immunotherapeutics such as anti-CTLA-4 or anti-PD-1 antibodies that both target negative immune-regulatory pathways on immune cells resulting in durable responses in a proportion of patients, the importance of the interplay between the immune system and cancer has been established beyond doubt.
URI: http://ahro.austin.org.au/austinjspui/handle/1/17459
DOI: 10.1111/imcb.12001
ORCID: 0000-0003-4289-5204
0000-0001-5329-280X
PubMed URL: 29392770
Type: Journal Article
Review
Subjects: Immune homeostasis
immunotherapy
melanoma
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.